A final common pathway for anti-inflammatory agents: inhibition of leukocyte-endothelial interactions.
Kimmel
S C
SC
Department of Medicine, NYU Medical Center, NY 10016.
van de Stouwe
M J
MJ
Levin
R I
RI
Weissmann
G
G
Cronstein
B N
BN
D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D002448:Cell Adhesion / Q000187:drug effects; D015815:Cell Adhesion Molecules / Q000378:metabolism; D002478:Cells, Cultured; D003907:Dexamethasone / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D007962:Leukocytes / Q000187:drug effects* / Q000502:physiology; D012980:Sodium Salicylate / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D015815:Cell Adhesion Molecules; D003907:Dexamethasone; D012980:Sodium Salicylate